Abstract The emergence of non-hallucinogenic psychoplastogens signals a profound philosophical and therapeutic chasm in the discourse surrounding psychedelic medicine. Unlike psychedelic-assisted therapy, which emphasizes subjective experience as central to healing, psychoplastogens are framed as purely neuroplasticity-driven treatments, aiming to repair brain circuits without inducing altered...
Abstract The vexed ‘psychotomimetic model’ of psychedelics claims to offer insights into both psychedelic experiences and psychosis, by weaving across these sets of experiences. One enduring opposition to the model distinguishes between psychedelic experiences as voluntary or ‘willed’, and psychosis as an affliction to be endured. This opposition is useful for projects seeking to sanitise and...